Skip to main content

Colorectal Cancer Clinical Trials

Review the colorectal cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 226-250 of 434

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Status: Active
Location: 2 locations
Y-NM600 in Combination with Immune Checkpoint Inhibitors in Treating Patients with Metastatic Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Status: Active
Location: Hackensack University Medical Center, Hackensack, New Jersey
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Status: Active
Location: 2 locations
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Adaptive, Individualized Dose Escalation of the FOX Regimen for the Treatment of Metastatic or Locally Advanced/Inoperable Gastrointestinal Cancer
Status: Active
Location: Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Profiling and Targeting Dynamic Tumor Resistance in Patients with Metastatic Colorectal Cancer, The ASCEND-CRC Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
High Dose Rate Brachytherapy after Neoadjuvant Therapy to Avoid Major Surgery in Patients with Low-Lying Rectal Adenocarcinoma
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Circulating Tumor DNA for Risk Determination and Treatment Selection in Patients with Carcinomatosis from Colorectal or Appendiceal Adenocarcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Mass-Based Response Testing to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Appendix and Colorectal Cancer in Patients with Peritoneal Metastasis
Status: Active
Location: Yale University, New Haven, Connecticut
A Precision Oncology Navigation and Expert Review Intervention for Improving Referral to Genome Informed Therapy among Patients with Stage IV Lung, Colorectal, Breast or Bladder Cancers, PROGRESS Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Status: Active
Location: See ClinicalTrials.gov
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Status: Active
Location: See ClinicalTrials.gov
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Status: Active
Location: See ClinicalTrials.gov
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of HB0045 Injection in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Status: Active
Location: USC / Norris Comprehensive Cancer Center, Los Angeles, California